LM
TEVA icon

Lincluden Management’s Teva Pharmaceuticals TEVA Stock Holding History

Lincluden Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-55,634
Closed -$1.85M – 81
2017
Q2 		$1.85M Sell
55,634
-26,695
-32% -$826K 0.16% 62
2017
Q1 		$2.64M Buy
82,329
+23,475
+40% +$801K 0.24% 59
2016
Q4 		$2.13M Buy
58,854
+4,272
+8% +$171K 0.23% 63
2016
Q3 		$2.51M Buy
54,582
+735
+1% +$38.3K 0.37% 63
2016
Q2 		$2.71M Buy
53,847
+8,017
+17% +$427K 0.45% 58
2016
Q1 		$2.45M Buy
45,830
+50
+0.1% +$2.93K 0.41% 60
2015
Q4 		$3M Sell
45,780
-1,310
-3% -$81K 0.61% 50
2015
Q3 		$2.66M Sell
47,090
-2,940
-6% -$191K 0.51% 52
2015
Q2 		$2.96K Sell
50,030
-17,510
-26% -$1.08M 0.36% 47
2015
Q1 		$4.21M Buy
67,540
+13,870
+26% +$806K 0.6% 46
2014
Q4 		$3.09M Sell
53,670
-27,253
-34% -$1.52M 0.3% 58
2014
Q3 		$4.35M Buy
80,923
+1,809
+2% +$95.8K 0.42% 52
2014
Q2 		$4.15M Buy
79,114
+9,518
+14% +$486K 0.38% 57
2014
Q1 		$3.68M Sell
69,596
-10,502
-13% -$485K 0.35% 56
2013
Q4 		$3.21M Buy
80,098
+6,207
+8% +$244K 0.29% 57
2013
Q3 		$2.79M Buy
+73,891
New +$2.88M 0.35% 55

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lincluden Management's TEVA Position: Q3 2017 in Review

Lincluden Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 55,634 shares — an estimated $1.85M sold.

Lincluden Management first reported a position in TEVA in Q3 2013 and held it in 16 quarters. The position peaked at $4.35M in Q3 2014. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Lincluden Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Lincluden Management sold 55,634 Teva Pharmaceuticals shares in Q3 2017, an estimated $1.85M.
  • Lincluden Management first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 16 quarters.
  • Lincluden Management's Teva Pharmaceuticals position peaked at $4.35M in Q3 2014.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Lincluden Management's 13F filing for Q3 2017, filed 2 Nov 2017.